- Home
- IMNM vs NXP Comparison
IMNM vs NXP Comparison
Compare IMNM & NXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- NXP
- Stock Information
- Founded
- IMNM 2006
- NXP 1992
- Country
- IMNM United States
- NXP United States
- Employees
- IMNM N/A
- NXP N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- NXP Trusts Except Educational Religious and Charitable
- Sector
- IMNM Health Care
- NXP Finance
- Exchange
- IMNM Nasdaq
- NXP Nasdaq
- Market Cap
- IMNM 747.7M
- NXP 715.7M
- IPO Year
- IMNM 2020
- NXP N/A
- Fundamental
- Price
- IMNM $9.91
- NXP $14.55
- Analyst Decision
- IMNM Strong Buy
- NXP
- Analyst Count
- IMNM 5
- NXP 0
- Target Price
- IMNM $28.60
- NXP N/A
- AVG Volume (30 Days)
- IMNM 695.8K
- NXP 70.0K
- Earning Date
- IMNM 11-13-2024
- NXP 01-01-0001
- Dividend Yield
- IMNM N/A
- NXP 4.04%
- EPS Growth
- IMNM N/A
- NXP N/A
- EPS
- IMNM N/A
- NXP 0.54
- Revenue
- IMNM $10,129,000.00
- NXP N/A
- Revenue This Year
- IMNM N/A
- NXP N/A
- Revenue Next Year
- IMNM N/A
- NXP N/A
- P/E Ratio
- IMNM N/A
- NXP $26.81
- Revenue Growth
- IMNM N/A
- NXP N/A
- 52 Week Low
- IMNM $6.93
- NXP $12.91
- 52 Week High
- IMNM $30.96
- NXP $14.89
- Technical
- Relative Strength Index (RSI)
- IMNM 30.69
- NXP 36.80
- Support Level
- IMNM $12.46
- NXP $14.55
- Resistance Level
- IMNM $13.52
- NXP $14.77
- Average True Range (ATR)
- IMNM 0.85
- NXP 0.16
- MACD
- IMNM -0.15
- NXP -0.01
- Stochastic Oscillator
- IMNM 6.71
- NXP 4.35
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About NXP Nuveen Select Tax Free Income Portfolio
Nuveen Select Tax Free Income Portfolio is a diversified closed-end investment company. It seeks to provide current income and stable dividends, exempt from regular federal and designated state income taxes, consistent with the preservation of capital by investing primarily in a portfolio of municipal obligations.